Publicaciones en colaboración con investigadoras/es de Assistance Publique -Hopitaux De Paris (11)

2023

  1. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

  2. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2020

  1. 2018 updated European League against Rheumatism evidence-based recommendations for the diagnosis of gout

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 1, pp. 31-38

2019

  1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

  2. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 2, pp. 374-382

  3. Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: Preliminary data from the ADVENT-HF trial

    European Respiratory Journal

2018

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 6, pp. 1074-1082

2017

  1. 2016 updated EULAR evidence-based recommendations for the management of gout

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 29-42

2016

  1. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 5, pp. 795-810

2011

  1. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2372-2378

2007

  1. Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?

    Arthritis Care and Research, Vol. 57, Núm. 7, pp. 1324-1328